Clinical trials in Leidschendam – page 153

1 919 clinical trials in Leidschendam, The Netherlands across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in the NetherlandsKlinischOnderzoek.nl

Leidschendam at a glance

1 919

clinical trials

Research sites1

Quick filters

1 919 trials in Leidschendam

Open in trial search

Small cell lung cancer recurrent

Not recruiting

Study comparing tarlatamab with topotecan in patients with relapsed small cell lung cancer after first-line chemotherapy

Registered drugNo placebo

Study comparing tarlatamab with topotecan in patients with relapsed small cell lung cancer after first-line chemotherapy

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Dexamethasone
Sponsor:Amgen Inc.

Contact Research Centre

Prinzmetal angina

Not recruiting

Study on the Effects of Vericiguat on Patients with Vasospastic Angina

Registered drug

Study on the Effects of Vericiguat on Patients with Vasospastic Angina

Registered drug

The Netherlands

Participants:18–64 years · 65+ years
Substances:Insulin Aspart
Sponsor:Amsterdam UMC Stichting

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Study of TAS3351 for Patients with Advanced Non-Small Cell Lung Cancer with EGFR Mutations

InvestigationalNo placebo

Study of TAS3351 for Patients with Advanced Non-Small Cell Lung Cancer with EGFR Mutations

InvestigationalNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:TAS3351
Sponsor:Taiho Oncology Inc.

Contact Research Centre

Anal fistula+1

Not recruiting

Study on the Effectiveness and Safety of Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells for Treating Complex Perianal Fistulas in Children with Crohn's Disease

Registered drugNo placebo

Study on the Effectiveness and Safety of Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells for Treating Complex Perianal Fistulas in Children with Crohn's Disease

Registered drugNo placebo

The Netherlands

Participants:0–17 years
Sponsor:Takeda Development Center Americas Inc.

Contact Research Centre

Pulmonary sarcoidosis

Not recruiting

Study on Efzofitimod for Treating Pulmonary Sarcoidosis in Patients

Registered drug

Study on Efzofitimod for Treating Pulmonary Sarcoidosis in Patients

Registered drug

The Netherlands

Participants:18–64 years · 65+ years
Substances:Efzofitimod
Sponsor:aTYR Pharma Inc.

Contact Research Centre

Food allergy

Not recruiting

Study on the Effectiveness and Safety of DBV712 for Peanut Allergy in Children Aged 4-7

Registered drug

Study on the Effectiveness and Safety of DBV712 for Peanut Allergy in Children Aged 4-7

Registered drug

The Netherlands

Participants:0–17 years
Substances:Water For Injection
Sponsor:Dbv Technologies

Contact Research Centre

Ischaemic stroke

Not recruiting

Study on the Safety and Effectiveness of Tenecteplase for Patients with Acute Ischemic Stroke and Incomplete Reperfusion After Mechanical Thrombectomy

Registered drugNo placebo

Study on the Safety and Effectiveness of Tenecteplase for Patients with Acute Ischemic Stroke and Incomplete Reperfusion After Mechanical Thrombectomy

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Tenecteplase
Sponsor:Insel Gruppe AG

Contact Research Centre

Bladder cancer

Not recruiting

Study of Pembrolizumab, Vibostolimab, and Favezelimab for Patients with High-Risk Non-Muscle Invasive Bladder Cancer Unresponsive to BCG Therapy

Registered drugNo placebo

Study of Pembrolizumab, Vibostolimab, and Favezelimab for Patients with High-Risk Non-Muscle Invasive Bladder Cancer Unresponsive to BCG Therapy

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Pembrolizumab
Sponsor:Merck Sharp & Dohme LLC

Contact Research Centre

Sickle cell anaemia with crisis+1

Not recruiting

Study on Crovalimab for Preventing Painful Episodes in Sickle Cell Disease Patients

Investigational

Study on Crovalimab for Preventing Painful Episodes in Sickle Cell Disease Patients

Investigational

The Netherlands

Participants:0–17 years · 18–64 years
Sponsor:F. Hoffmann-La Roche AG

Contact Research Centre

Dry age-related macular degeneration

Not recruiting

Study on JNJ-81201887 for Treating Geographic Atrophy in Age-related Macular Degeneration Patients

Registered drug

Study on JNJ-81201887 for Treating Geographic Atrophy in Age-related Macular Degeneration Patients

Registered drug

The Netherlands

Participants:18–64 years · 65+ years
Substances:Prednisone
Sponsor:Janssen Cilag International

Contact Research Centre

Cholangitis sclerosing

Not recruiting

Study on Volixibat for Treating Itching in Patients with Primary Sclerosing Cholangitis

Investigational

Study on Volixibat for Treating Itching in Patients with Primary Sclerosing Cholangitis

Investigational

The Netherlands

Participants:0–17 years · 18–64 years · 65+ years
Substances:Volixibat
Sponsor:Mirum Pharmaceuticals Inc.

Contact Research Centre

COVID-19

Not recruiting

Study on the Effectiveness and Safety of Bemnifosbuvir for High-Risk COVID-19 Patients

Registered drug

Study on the Effectiveness and Safety of Bemnifosbuvir for High-Risk COVID-19 Patients

Registered drug

The Netherlands

Participants:0–17 years · 18–64 years · 65+ years
Substances:Nirmatrelvir
Sponsor:Atea Pharmaceuticals Inc.

Contact Research Centre

Other cities in the Netherlands

The busiest research cities in the country

All 101 cities in the Netherlands

Clinical research in Leidschendam

What the registry says about research in the country

01 Oncology - Lung Cancer Research

Multiple clinical trials focusing on non-small cell lung cancer (NSCLC) treatment advancements, evaluating novel therapeutic approaches including immunotherapy combinations and targeted treatments.

Advanced NSCLC treatments
Immunotherapy combinations
KRAS G12C inhibitors

Studies compare various treatment options to improve patient outcomes and survival rates.

02 Breast Cancer Studies

Comprehensive research into breast cancer treatments, particularly focusing on hormone receptor-positive and HER2-positive subtypes, investigating targeted therapies and chemotherapy combinations.

Metastatic breast cancer
HER2-positive therapy
Triple-negative breast cancer

Trials examine innovative treatment strategies and personalized approaches.

03 Hematologic Malignancies

Studies focusing on lymphoma treatments, including both Hodgkin and non-Hodgkin variants, evaluating response-adapted therapies and novel drug combinations.

Advanced Hodgkin Lymphoma
Follicular Lymphoma
Treatment optimization

Research aims to improve treatment outcomes while minimizing toxicity.

04 Gastrointestinal Oncology

Investigations into colorectal cancer and related conditions, including innovative surgical approaches and treatment strategies for recurrent disease.

Rectal cancer treatments
Esophagogastric cancer
Surgical innovations

Focus on improving surgical outcomes and treatment effectiveness.

05 Brain Metastases Research

Studies examining treatment options for cerebral radiation necrosis and brain metastases, including innovative detection methods and therapeutic approaches.

Radiation necrosis treatment
Metastatic detection
Targeted therapies

Research aims to improve detection and treatment of brain metastases.

Back to the Netherlands All countries